Aperio Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Aperio Group’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-9,021	Closed	-$908K	–	2039
2014 Q4	$908K	Buy	9,021 +1,636	+22%	+$127K	0.01%	949
2014 Q3	$490K	Sell	7,385 -235	-3%	-$15.4K	0.01%	1144
2014 Q2	$532K	Buy	7,620 +2,914	+62%	+$198K	0.01%	1096
2014 Q1	$344K	Buy	+4,706	New	+$351K	﹤0.01%	1529
2013 Q4	–	Sell	-4,463	Closed	-$289K	–	1525
2013 Q3	$284K	Buy	+4,463	New	+$270K	0.01%	1455

Aperio Group's CBST Position: Q1 2015 in Review

Aperio Group sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 9,021 shares — an estimated $908K sold.

Aperio Group first reported a position in CBST in Q3 2013 and held it in 5 quarters. The position peaked at $908K in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Aperio Group reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Aperio Group sold 9,021 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $908K.
Aperio Group first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 5 quarters.
Aperio Group's CUBIST PHARMACEUTICALS INC position peaked at $908K in Q4 2014.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Aperio Group's 13F filing for Q1 2015, filed 29 Apr 2015.